Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [<sup>18</sup>F]FDG.

Eur J Nucl Med Mol Imaging · 2024 · PMC10796439 · PMID 37943339

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

just missed significanceP = 0.06so close (0.05 < p ≤ 0.1)

Those findings on image contrast, however, were driven by nodal MZL ( P < 0.01), and just missed significance for extranodal MZL ( P = 0.06).

also in 22 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [&lt;sup&gt;18&lt;/sup&gt;F]FDG.

The sentences

Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [<sup>18</sup>F]FDG.